Liaoning He Eye Hospital Group (301103.SZ) issues a profit warning, expecting a net loss of 20.5 million to 30.75 million yuan in 2024, turning from profit to loss.
He Medical Ophthalmology (301103.SZ) released the 2024 annual performance forecast, with the company expecting...
Liaoning He Eye Hospital Group (301103.SZ) released the performance forecast for the year 2024, with the company expecting a net loss attributable to shareholders of the listed company of 20.5 million yuan to 30.75 million yuan, a switch from profit to loss; a net loss of 22 million yuan to 32.5 million yuan after deducting non-recurring gains and losses, also a switch from profit to loss.
During the reporting period, intensified industry competition and the impact of healthcare payment reform caused a decrease in the company's revenue and gross profit. The company has invested heavily in innovative business, digitalization, and R&D projects, resulting in increased cost and expense compared to the same period last year.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


